RxDoctor Payments DataLook up a doctor →

Hasanian Jilaihawi, MD

Interventional Cardiology · West Hollywood, CANPI 1699020859

Payments from drug & device makers

$768,313in general payments, 2019–2025

Across 535 payments — averaging $1436.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$669K
  • Edwards Lifesciences$62K
  • Abbott$21K
  • Pi-cardia, Inc.$12K
  • Abiomed$2K
  • Heartflow, Inc.$1K
  • plus $2K from 4 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)94$668,823
Edwards Lifesciences370$61,892
Abbott6$20,872
Pi-cardia, Inc.2$12,057
Abiomed25$1,635
Heartflow, Inc.19$1,135
Boston Scientific12$876
Philips North America LLC5$703
Jenavalve Technology, Inc.1$173
GE HealthCare1$146

How this compares

$768,313 in reported general payments places this provider in the 95th percentile of 585 interventional cardiology providers in California.

See all interventional cardiology providers in California

Medicare billing

Part B allowed, 2024
$9,775
Medicare patients
26
Services billed
47

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in West Hollywood

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →